Inventor

SKOTTNER ANNA

SE12 patents

⚠️ This page may combine multiple inventors who share the name “SKOTTNER ANNA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LUNDSTEDT TORBJOERN

3 patents

US8148429B2Apr 3, 2012

Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands

LUNDSTEDT TORBJOERN7 citations81

US8410174B2Apr 2, 2013

Method for treating arthritis

LUNDSTEDT TORBJOERN2 citations60

US8309609B2Nov 13, 2012

Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands

LUNDSTEDT TORBJOERN2 citations60

CHIRON CORP

2 patents

US6034059AMar 7, 2000

Treatment of catabolic states using authentic IGF-1 and hypocaloric amount of nutrients

CHIRON CORP11 citations72

US5994303ANov 30, 1999

Use of insulin and IGF-I

CHIRON CORP12 citations68

ACTION PHARMA AS

2 patents

US7442807B2Oct 28, 2008

N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands

ACTION PHARMA AS7 citations71

US7186748B2Mar 6, 2007

N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands

ACTION PHARMA AS5 citations60

KABIVITRUM AB

1 patent

US5068224ANov 26, 1991

Method of improving regeneration of transfected peripheral nerves using igf-1

KABIVITRUM AB94 citations90

PHARMAC IA AB

1 patent

US5434134AJul 18, 1995

Use of human IGF-1 to treat cardiac disorders

PHARMAC IA AB32 citations88

ACURE PHARMA AB

1 patent

US7153881B2Dec 26, 2006

Compounds acting as melanocortin receptor ligands

ACURE PHARMA AB15 citations79

PHARMACIA & UPJOHN AB

1 patent

US5756463AMay 26, 1998

Use of insulin and IGF-1

PHARMACIA & UPJOHN AB4 citations57

ANAMAR AB

1 patent

US9227927B2Jan 5, 2016

Method of treating inflammation

ANAMAR AB0 citations47